SEC Company Response from Aspira Women's Health Inc. (AWHL) (CIK 0000926617) (AWHL) — Feb 10, 2011
Aspira Women's Health Inc. (AWHL) (CIK 0000926617)
Date: Feb. 10, 2011 · CIK: 0000926617 · Accession: 0001193125-11-031145
AI Filing Summary & Sentiment
File numbers found in text: 333-171797
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request Letter 12117 Bee Caves Road Building Two, Suite 100 Austin Texas 78738 www.vermillion.com February 10, 2011 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, DC 20549 Re: Vermillion, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-171797 Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 8:00 AM Eastern Time on February 14, 2011, or as soon thereafter as is practicable. The Company hereby acknowledges that: ¨ Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; ¨ The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and ¨ The Company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Very truly yours, Vermillion, Inc. By: /s/ Sandra A. Gardiner Name: Sandra A. Gardiner Title: Vice President and Chief Financial Officer